A class of injectable drugs that biohackers, athletes and celebrities have been buying through gray-market vendors for years may soon have a legal path through compounding pharmacies. Whether that path is as wide as the headlines suggest is another question, and the answer affects anyone weighing peptide therapy for skin, recovery or anti-aging.
On "The Joe Rogan Experience" podcast in February 2026, Health and Human Services Secretary Robert F. Kennedy Jr. said roughly 14 of the 19 peptides the FDA restricted in 2023 would return to legal compounding status. Reporting from Pharmacy Times and the Associated Press has since filled in the picture, and the FDA's own advisory committee schedule tells a narrower story.
These same compounds already show up as some of the priciest line items on typical biohacking clinic menus, which is part of why this regulatory fight matters to anyone pricing out a visit.
Read Full Article Here
